23.08.2011 Copyright® Raisio Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment.

Slides:



Advertisements
Similar presentations
Copyright® Raisio Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and.
Advertisements

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
Monascus rice powder co-supplemented with coenzyme Q 10 improves serum lipids and LDL-lag time on hypercholesterolemia subjects. Shih-Wen Hsu 1#, Yi-Ting.
ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
Plant stanol ester in the treatment and prevention guidelines 0.
Copyright® Raisio A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results.
Pathway of Exogenous Cholesterol Metabolism
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
Plant Sterols Roles in Margarines Pennington Biomedical Research Center Division of Education Heli J. Roy PhD Shanna Lundy, BS Phillip Brantley, PhD, Director.
Epanova ® - Omega-3- carboxylic acids Manufacturer: AstraZeneca FDA Approval Date: 05/2014.
Cholesterol Metabolism
ROLE OF PLANT STEROLS AND STANOLS IN A CHOLESTEROL LOWERING DIET
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Natural Cholesterol Reduction: Latest Development in Functional Foods Rebecca S. Reeves, DrPH, RD Iowa Dietetic Association Meeting December 5, 2008.
 High density lipoproteins (HDL) protect against cardiovascular disease  A novel mechanism for raising HDL levels is to inhibit a protein known as CETP.
Copyright® Raisio Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic.
Downloaded from Slide 1 Dual Inhibition of Two Sources of Cholesterol: Absorption and Production in Patients with Type 2 Diabetes.
BackgroundBackground HDL-C levels are inversely related to CV event rates. HDL-C levels are inversely related to CV event rates. Torcetrapib, a cholesteryl.
Copyright® Raisio The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins Gylling et.
SECONDARY PREVENTIONS Jaimon Stucki MS-1 PSCOM. Blood Draw.
Slide 1 Downloaded from Ezetimibe Factorial Coadministration Studies.
Copyright® Raisio A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol.
© Copyright 2009 by the American Association for Clinical Chemistry Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals With and Without.
Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary.
Copyright® Raisio Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population Miettinen TA et.
Copyright® Raisio Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced.
Moderate Amounts of Fructose Consumption Impair Insulin Sensitivity in Healthy Young Men: A Randomized Controlled Trial Featured Article: Isabelle Aeberli,
Cholesterol Metabolism and the Concept of Dual Inhibition David E. Cohen, MD, PhD.
Ezetimibe Overall Conclusions
Copyright® Raisio Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and.
Downloaded from Slide 1 Dual Inhibition of Two Sources of Cholesterol: Absorption and Production Results of a Clinical Trial.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised,placebo-controlled.
Plant stanol and sterol esters - mechanism and safety issues -
Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.
Overview Lipoprotein metabolism Digestive lipid metabolism
Plant stanol esters in human studies Professor Helena Gylling University of Kuopio.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans Bonnie Ky, MD,* Anne Burke, MD,* Sotirios Tsimikas,
Marina Cuchel, M.D., Ph.D., LeAnne T. Bloedon, M.S., R.D.,Philippe O. Szapary, M.D., Daniel M. Kolansky, M.D., Megan L. Wolfe, B.S., Antoine Sarkis, M.D.,
HEARTS & MINDS Lowering Cholesterol with Plant Stanol Ester Opening Remarks Herbert Schuster, M.D., Ph.D. Humboldt University Berlin, Berlin, Germany.
Therapeutic Lifestyle
Cholesterol-Lowering Ability of a Phytostanol Softgel Supplement in Adults with Mild to Moderate Hypercholesterolemia Woodgate D et al. Lipids. 2006;41:
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
Westerweel PE et al. Eur Heart J 2008;29:
Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.
Baseline Characteristics of the Patients Part I
First time a CETP inhibitor shows reduction of serious CV events
Copyright © 2012 American Medical Association. All rights reserved.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Cardiovascular System
National Cholesterol Education Program
The ASSERT Study.
Associations of Diet and Lifestyle with Hyperlipidemia for the Middle-Aged and Elderly in the Guangxi Bai Ku Yao and Han Populations Yin Ruixing, MD: Guangxi.
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.
Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial  Erik S.G. Stroes, MD, PhD, Andrey.
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
Presented by Christina Bullerwell
Sudhop T. et al. J Lipid Res 2009 Apr 20 [Epub ahead of print]
Figure 1 Statins, ezetimibe, and PCSK9 inhibitors all increase the expression of LDL receptors and reduce LDL-cholesterol levels (by percentages shown)
Body mass, BMI, plasma lipids, lipoproteins, and glucose homeostasis at baseline, and following placebo and rosuvastatin periods Dmitri Sviridov et al.
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]
The Heart Rhythm Society Meeting Presented by Dr. Johan De Sutter
(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.
Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage),
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Serum bicarbonate increased by ≥3, ≥4, and ≥5 mEq/L in 52%, 39%, and 22% of patients, respectively, in the combined TRC101 dose group compared with 6%,
Presentation transcript:

Copyright® Raisio Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment de Jong et al. Br J Nutr 2008; 100:

de Jong et al Background Subjects on statins may not reach the cholesterol target Plant stanol ester consumption has been shown to be effective in statin using subjects: Statin drug and plant stanol ester have different cholesterol lowering mechanisms: Statins inhibit cholesterol synthesis Plant stanols reduce the absorption of cholesterol in intestine The aim of the study was to confirm that the serum LDL- cholesterol-lowering effect of plant stanol ester is sustained also in statin using subjects.

de Jong et al Methods I 54 subjects on stable statin treatment 1.5 week run-in with placebo margarine 2.randomization to 3 different treatment groups for 85 weeks placebo margarine (n=17) plant stanol ester margarine (2,5 g/d plant stanols) (n=19) plant sterol ester margarine (2,5 g/d plant sterols) (n=18)

de Jong et al Methods II Blood samples were collected in the beginning and in the end on run-in period duplicate samples in 5, 25, 45, 65 and 85 weeks into the study analyses for lipids and apolipoproteins; plant stanols and plant sterols and markers of cholesterol metabolism

de Jong et al Results I Calculated daily plant stanol/sterol intake was 2.5 g  Study subjects adhered well to the guidance given regarding the use of the test products No differences in the energy intake or the nutrient composition of the diet at base-line or during the study, no weight-change

de Jong et al Results II Plant stanol consumption lowered total cholesterol by 9.4 % and LDL-C by 13.1 % compared to placebo (p=0.003 & 0.006) Plant sterol consumption lowered total cholesterol by 5.1 % and LDL-cholesterol by 8.7 % compared to placebo (p=0.092 & 0.080)

de Jong et al Plant stanol ester effectively reduces LDL cholesterol in combination with stable statin treatment * * * p<0.05 THE CHOLESTEROL-LOWERING EFFECT IS LASTING ALSO IN STATIN USING SUBJECTS Plant sterol ester (2.5 g/day plant sterol) Change (%) in LDL cholesterol Run-in period Week 45Week 85 Plant stanol ester (2.5 g/day plant stanol)

de Jong et al Conclusions Consumption of plant stanol ester significantly reduces serum total and LDL-cholesterol levels in subjects on stable statin drug use The cholesterol-lowering effect is lasting also in statin using subjects.

9 Thank You!